Peptide Initiative
Back to Cerebrolysin

Clinical trials

Every registered trial of Cerebrolysin

53 studies, 7 still enrolling.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Cerebrolysin has a real but limited body of human research.
  • 53 registered studies in total.
  • 7 are still enrolling people, so this is active research, not just history.

What kind of research

  • 49 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 6,394 people took part in those.
  • A further 4 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 53 of 53 trials for Cerebrolysin.

  • NCT06339411 Phase 2Not Yet Recruiting100 enrolled2026

    Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy

    Chang Gung Memorial Hospital

    Acute Ischemic Stroke

  • 2025-521350-41-01 Ongoing416 enrolled2025

    FSNANO28012025

    Foundation For The Study Of Nanoneuroscience And Neuroregeneration

    Stroke

  • NCT06899464 Phase 4Not Yet Recruiting30 enrolled2025

    Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

    Cardinal Stefan Wyszynski University

    Intracerebral Hemorrhage · Hemorrhagic Stroke, Intracerebral · Hemorrhagic Stroke · Stroke

  • NCT07043686 Recruiting30 enrolled2025

    Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

    University Medical Centre Ljubljana

    Ischemic Stroke, Acute · Rehabilitation Outcome · Cerebrolysin

  • NCT06897176 Phase 4Recruiting40 enrolled2025

    Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study

    Yonsei University

    Stroke

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-515591-12-00 Ongoing440 enrolled2024

    C-RETURN

    Foundation For The Study Of Nanoneuroscience And Neuroregeneration

    Traumatic brain injury

  • NCT06489925 Early Phase 1Unknown20 enrolled2024

    Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion

    University Hospital Sestre Milosrdnice

    Basilar Artery Occlusion · Posterior Circulation Brain Infarction

  • Add-on benefit of cerebrolysin to acute stroke patients given recombinant tissue plasminogen activator

    Baguio General Hospital and Medical Center

    Acute ischemic stroke after intravenous thrombolysis

  • Triple therapy to boost stroke recovery in Azerbaijan: combining brain stimulation, medication, and physiotherapy

    Azerbaijan Medical University

    To study the effectiveness of the use of cerebrolysin in combination with physical methods of treatment (direct current stimulation, kinesitherapy, massage) in the rehabilitation of patients with cerebral stroke.

  • NCT06677502 Enrolling By Invitation500 enrolled2024

    Cerebrolysin in Critically Ill Patients With Delirium

    Medical University of Lublin

    Cognitive Impairment

  • NCT05755997 Phase 2Active Not Recruiting30 enrolled2023

    CERebrolysin In CADASIL

    Ever Neuro Pharma GmbH

    Cadasil

  • 2024-513828-42-00 Temporarily Halted30 enrolled2023

    CERICA - CERebrolysin In CADASIL - A randomized, double-blind, single-centre, two-period cross-over, placebo-controlled trial on safety and efficacy in patients with genetically proven CADASIL

    Ever Neuro Pharma GmbH

    Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy (CADASIL)

  • NCT06070753 Unknown30 enrolled2023

    A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)

    Shaare Zedek Medical Center

    Acute Ischemic Stroke

  • NCT06052787 Phase 3Completed150 enrolled2023

    Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU

    Ain Shams University

    Traumatic Brain Injury

  • NCT05821075 Phase 1/2Recruiting90 enrolled2023

    Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

    October 6 University

    Bell Palsy

  • NCT04427241 Phase 4Recruiting12 enrolled2023

    Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

    Konkuk University Medical Center

    Disorder of Consciousness · Hemorrhagic Stroke

  • NCT05864677 Unknown100 enrolled2023

    Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery

    Medical University of Lublin

    Neurocognitive Disorders · Surgery-Complications · Critical Illness · Brain Damage

  • NCT06078215 Phase 4Unknown350 enrolled2023

    CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke

    Poznan University of Medical Sciences

    Acute Ischemic Stroke

  • NCT06273020 Phase 4Unknown60 enrolled2022

    Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

    Hospital Universitario Dr. Jose E. Gonzalez

    Ischemic Stroke, Acute · Diabetes Mellitus, Type 2 · Blood Brain Barrier

  • NCT06208540 Phase 4Completed160 enrolled2021

    Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

    Sherifa Ahmed Hamed

    Post-covid-19 Persistent Smell and Taste Disorders

  • Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosis

    Instituto Cardiológico Banfield

    Amyotrophic lateral sclerosis

  • NCT04124367 Phase 2Terminated4 enrolled2021

    IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE

    Ever Neuro Pharma GmbH

    Chronic Stroke · Subacute Stroke

  • NCT04913831 Phase 4Unknown30 enrolled2021

    Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study

    Yonsei University

    Stroke

  • NCT05124353 Phase 2/3Unknown100 enrolled2021

    Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

    Pomeranian Medical University Szczecin

    Stroke, Acute, Ischemic

  • NCT06429943 Completed47 enrolled2021

    Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

    Pomeranian Medical University Szczecin

    SAH (Subarachnoid Hemorrhage)

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04904341 Phase 3Unknown50 enrolled2021

    Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.

    Military Institute od Medicine National Research Institute

    Stroke, Ischemic · Stroke, Acute · Stroke Sequelae

  • NCT04830943 Phase 3Completed250 enrolled2020

    Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

    Assiut University

    Covid19 Related Anosmia and Aguesia

  • Can treatment with Cerebrolysin improve recovery after acute ischemic stroke?

    The foundation for the study of neuroscience and neuroregeneration

    Radiologically confirmed acute ischemic stroke with onset within 72 hours prior to screening

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • Can Cerebrolysin improve aphasia after ischemic stroke?

    The foundation for the study of neuroscience and neuroregeneration (SSNN)

    Patients with Broca or mixed non-fluent aphasia post ischemic stroke with onset 3-5 days prior to inclusion

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05807503 Completed56 enrolled2020

    Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

    Pomeranian Medical University Szczecin

    TBI (Traumatic Brain Injury)

  • Can adding cerebrolysin early to clot-dissolving stroke treatment reduce the risk of brain bleeding?

    State Autonomous Institution of Health Interregional Clinical Diagnostic Center

    Ischemic stroke

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03480698 Completed1,851 enrolled2018

    Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness

    Ever Neuro Pharma GmbH

    Acute Ischemic Stroke

  • Can treatment with Cerebrolysin and magnetic stimulation of the brain improve recovery after traumatic brain injury?

    EN: The foundation for the study of neuroscience and neuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)

    Traumatic Brain Injury (TBI) onset 30 days prior to screening

  • Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapy

    University Hospital Centre Zagreb

    Acute ischemic stroke

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04751136 Phase 2Completed64 enrolled2016

    the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

    Mansoura University Children Hospital

    Down Syndrome

  • NCT03506841 Phase 1Completed60 enrolled2016

    Cerebrolysin and Neurodevelopment in Preterm Infants

    Mansoura University Children Hospital

    Infant Development · Cerebral Palsy · Preterm Infant

  • NCT02768571 Phase 4Completed80 enrolled2016

    Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke

    Samsung Medical Center

    Stroke

  • NCT02581371 Phase 4Unknown30 enrolled2015

    Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

    Clinical Institute of the Brain, Russia

    Ischemic Stroke

  • NCT05288465 Completed5 enrolled2014

    Hair Repigmentation During Cerebrolysin Therapy

    Universidad Autonoma de Nuevo Leon

    Hair Problems

  • NCT02541227 Terminated1,823 enrolled2014

    Cerebrolysin REGistry Study in Stroke

    Ever Neuro Pharma GmbH

    Ischemic Stroke

  • NCT02116348 Phase 2Unknown100 enrolled2014

    Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

    Ain Shams University

    Cerebral Palsy Children · Children With Traumatic Brain Injury · Mental Handicap · Delayed Speech Development

  • NCT01787123 Phase 2/3Completed50 enrolled2013

    Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

    Kwong Wah Hospital

    Subarachnoid Hemorrhage · Intracranial Aneurysm · Delayed Cerebral Ischemia · Delayed Ischemic Neurological Deficit

  • NCT01606111 Phase 4Terminated46 enrolled2013

    The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

    Ever Neuro Pharma GmbH

    Traumatic Brain Injury

  • Can Cerebrolysin improve recovery after traumatic brain injury?

    EN: The foundation for the study of neuroscience and reuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)

    Traumatic brain injury (TBI) with Glasgow Coma Scale (GCS) scores between 7 and 12.

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01059461 Phase 2Completed40 enrolled2011

    Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

    Sahar M.A. Hassanein, MD

    Hypoxic-Ischemic Encephalopathy

  • NCT01996761 Phase 4Completed71 enrolled2011

    Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke

    Samsung Medical Center

    Cerebrolysin

  • NCT01388738 Phase 3Completed30 enrolled2011

    Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

    Clinical Institute of the Brain, Russia

    Stroke

  • NCT02149875 Phase 1/2Completed84 enrolled2010

    Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

    Shanghai 6th People's Hospital

    Acute Cerebral Stroke Within 12 Hours for the First Time

  • NCT00947531 Phase 4Completed242 enrolled2006

    A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

    Ever Neuro Pharma GmbH

    Vascular Dementia

  • NCT00868283 Phase 4Completed1,071 enrolled2006

    The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

    Ever Neuro Pharma GmbH

    Ischemic Stroke

  • NCT00840671 Phase 3Completed119 enrolled2005

    Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

    Ever Neuro Pharma GmbH

    Stroke

  • NCT00911807 Phase 2Completed217 enrolled2004

    Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

    Ever Neuro Pharma GmbH

    Alzheimer Disease

  • NCT01822951 Phase 4Withdrawn

    Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

    Ever Neuro Pharma GmbH

    Alzheimer Disease

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Cerebrolysin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.